Company: LENZ
Filing Date: 2025-03-19
Form Type: 10-K
Source: 0001815776-25-000019
Chunk: 205

Company: LENZ Therapeutics, Inc.
Filing Date: 2025-03-19
Form: 10-K
Item: Item 13
Chunk 205
---
, on account of any services undertaken by such person on behalf of Graphite or that person’s status as a member of the Graphite board of directors to the maximum extent allowed under Delaware law.

158

Table of Contents

Certain Relationships and Related Person Transactions—LENZ OpCo 

Private Placements of Securities

Series B Preferred Stock Financing. In March 2023, LENZ OpCo issued and sold an aggregate of 28,019,181 shares of its Series B Preferred Stock at a purchase price of $2.9801 per share for an aggregate purchase price of approximately $83.5 million.

Purchasers of LENZ OpCo’s Series B Preferred Stock included certain of its directors and holders of more than 5% of its capital stock at the time of the financing. The following table presents the number of shares and the total purchase price paid by these entities:

InvestorShares of SeriesB PreferredStockTotal PurchasePriceAlpha Wave Ventures II, LP(1)13,422,368$39,999,999 Point72 Biotech Private Investments, LLC-Series LT5,033,388$15,000,000 Entities affiliated with RA Capital(2)5,033,388$15,000,000 Entities affiliated with Versant Ventures(3)167,779$499,998 McCollum Living Trust(4)167,779$499,998 Entities affiliated with RTW167,779$499,998 

__________________

(1)Chris Dimitropoulos, a member of the LENZ OpCo board of directors until immediately prior to the effective time of the Merger, is an affiliate of Alpha Wave Ventures II, LP.

(2)Zach Scheiner, a member of the LENZ board of directors, is an affiliate of RA Capital.

(3)Clare Ozawa, a member of the LENZ OpCo board of directors until immediately prior to the effective time of the Merger, is an affiliate of Versant Ventures.

(4)James McCollum, a member of the LENZ board of directors, is the trustee of the McCollum Living Trust.

The number of shares and purchase price per share set forth above are prior to giving effect to the exchange in accordance with the Merger Agreement.

Investors’ Rights Agreement

LENZ OpCo was a party to an amended and restated investors’ rights agreement with certain holders of its capital stock, including Alpha Wave Ventures II, LP